We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. The PATHFNDR-2 trial enrolled adults with acromegaly who ...

Findings showed 56% of patients who received paltusotine achieved an IGF-1 level equal to or less than 1 times the ULN compared with 5% of those who received placebo. Treatment with paltusotine ...

We present a review of the epidemiological evidence for relations of prostate cancer risk to circulating total and bioavailable androgens, to alterations in the metabolism of insulin-like growth ...

November 18, 2008 — A randomized trial of MK-677, a growth hormone secretagogue, shows no benefit in slowing progression among patients with Alzheimer's disease (AD), despite the fact that it ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Back to Healio More than 80% of adults with acromegaly ...